Loading clinical trials...

Factors Associated With Pre-hypertension Among Children With Type 1 Diabetes Mellitus | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITING

Factors Associated With Pre-hypertension Among Children With Type 1 Diabetes Mellitus

Prevalence and Factors Associated With Pre-hypertension Among Children and Adolescent With Type 1 Diabetes Mellitus

NCT07172399•Sohag University

View on ClinicalTrials.gov

Summary

blood pressure of diabetic patients will be measured

Detailed Description

All the study participants will be examined for assessment of the height and weight using calibrated equipment, Body Mass Index (BMI) calculated and plotted against percentiles,Blood Pressure (BP) Measurement: * BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use. * Appropriate cuff size will be used based on mid-arm circumference. * Blood pressure will be measured in the non-dominant arm. * BP will be measured three times on at least two different occasions, after 5 minutes of rest, in a seated position. * The average of the readings will be recorded.

Eligibility

Age

6 - 18 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Children and adolescents aged 6 - 18 years, diagnosed with T1DM for at least 1 year and attending the Pediatric diabetes clinic at Sohag University Hospital will be included as cases.

Exclusion Criteria

•Children and adolescents with T1DM associated with autoimmune hypothyroidism or celiac disease and those who had received any form of corticosteroids therapy for any reason in the last 6 months will be excluded.
•\-

Locations (1)

Sohag university hospital

Sohag, Egypt

Key Dates

Start Date

July 26, 2025

Primary Completion Date

July 25, 2026

Completion Date

August 5, 2026

Last Updated

September 15, 2025

Enrollment

ESTIMATED participants

Conditions

Hypertension

Interventions

blood sampling

PROCEDURE

• BP will be measured using a calibrated, automated oscillometric device suitable for pediatric use.

OTHER

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITING

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

NCT07480265

Hypertension (HTN)Hyperhomocysteinemia+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 15, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Factors Associated With Pre-hypertension Among Children With Type 1 Diabetes Mellitus

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart

Preliminary Human Trials of F230 Tablets